May 14 (Reuters) - MEDIGENE AG MDG1k.DE :
* TOTAL REVENUE IN Q1 2020 DECREASED TO EUR1.40 M FROM
EUR2.10 M
IN Q1 2019
* AS OF 31 MARCH 2020, CASH AND CASH EQUIVALENTS AND
FIXED-TERM
DEPOSITS AMOUNTED TO EUR48.53 M
* Q1 (EBITDA) DECREASED BY EUR0.96 M ON PRIOR-YEAR QUARTER
(Q1
2019: EUR-4.99 M), AMOUNTING TO EUR-5.95 M
* MEDIGENE CONFIRMS ITS FINANCIAL FORECAST FOR 2020
* CURRENTLY, MEDIGENE EXPECTS NO MATERIAL INFLUENCE OF
COVID-19
PANDEMIC ON TOTAL REVENUE, RESEARCH AND DEVELOPMENT EXPENSES AND
LOSS AT EBITDA LEVEL
Source text for Eikon: ID:nPexrNdQ3a
Further company coverage: MDG1k.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))